Teva/Ranbaxy Launch First Generic Of Pfizer’s Accupril
This article was originally published in The Pink Sheet Daily
Executive Summary
Teva, which relinquished 180-day exclusivity, is marketing quinapril manufactured under Ranbaxy’s ANDA pursuant to a supply and distribution agreement. Teva/Ranbaxy’s product gets a jump on at least five other potential generic competitors; timing of the generic’s launch may have been earlier than expected by Pfizer.